Cardiovascular Disease Stocks List

Cardiovascular Disease Stocks Recent News

Date Stock Title
May 8 JNJ 10 Future Dividend Kings in the Next 5 Years or Less
May 8 IRWD Ironwood Pharmaceuticals Q1 2024 Earnings Preview
May 8 NBIX Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults
May 8 JNJ Analysts' 3 Favorite Dividend Aristocrats, Based On Latest Price Targets
May 8 NNOX USARAD, Nanox’s Teleradiology Subsidiary, Awarded Accreditation from The Joint Commission
May 8 JNJ Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
May 8 JNJ Neutrogena Lost Dermatologists and Missed Out on the $42 Billion Beauty Boom
May 8 LH Labcorp to Webcast Its Annual Meeting of Shareholders
May 8 LH Q1 2024 OPKO Health Inc Earnings Call
May 8 JNJ The Zacks Analyst Blog Highlights Tesla, Johnson & Johnson, Netflix, Abbott and ConocoPhillips
May 8 LH OPKO Health Inc (OPK) Q1 2024 Earnings Call Transcript Highlights: Strategic Moves Amid ...
May 7 LH US Bankruptcy Court approves Invitae sale to Labcorp
May 7 NBIX Neurocrine Biosciences to Present at the BofA Securities 2024 Health Care Conference
May 7 LH Invitae Receives Court Approval for Sale to Labcorp
May 7 JNJ 15 Best S&P 500 Dividend Stocks To Buy Now
May 7 JNJ Q1 Earnings Season Scorecard and Fresh Analyst Reports for Tesla, JNJ & Netflix
May 7 JNJ A Look at Pharma ETFs Post Q1 Earnings
May 7 JNJ Shockwave Medical (SWAV) Q1 Earnings Beat, Revenues Rise Y/Y
May 7 GILD Gilead Helps Put African Nation on Path To Eliminate Hepatitis C
May 7 NBIX Neurocrine Biosciences to Present Phase 3 Baseline Characteristics Data from the CAHtalyst™ Program of Crinecerfont in CAH, and Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH Studies at ECE 2024
Cardiovascular Disease

Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. Cardiovascular disease includes coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). Other CVDs include stroke, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, thromboembolic disease, and venous thrombosis.The underlying mechanisms vary depending on the disease. Coronary artery disease, stroke, and peripheral artery disease involve atherosclerosis. This may be caused by high blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol, poor diet, and excessive alcohol consumption, among others. High blood pressure results in 13% of CVD deaths, while tobacco results in 9%, diabetes 6%, lack of exercise 6% and obesity 5%. Rheumatic heart disease may follow untreated strep throat.It is estimated that 90% of CVD is preventable. Prevention of atherosclerosis involves improving risk factors through: healthy eating, exercise, avoidance of tobacco smoke and limiting alcohol intake. Treating risk factors, such as high blood pressure, blood lipids and diabetes is also beneficial. Treating people who have strep throat with antibiotics can decrease the risk of rheumatic heart disease. The use of aspirin in people, who are otherwise healthy, is of unclear benefit.Cardiovascular diseases are the leading cause of death globally. This is true in all areas of the world except Africa. Together they resulted in 17.9 million deaths (32.1%) in 2015, up from 12.3 million (25.8%) in 1990. Deaths, at a given age, from CVD are more common and have been increasing in much of the developing world, while rates have declined in most of the developed world since the 1970s. Coronary artery disease and stroke account for 80% of CVD deaths in males and 75% of CVD deaths in females. Most cardiovascular disease affects older adults. In the United States 11% of people between 20 and 40 have CVD, while 37% between 40 and 60, 71% of people between 60 and 80, and 85% of people over 80 have CVD. The average age of death from coronary artery disease in the developed world is around 80 while it is around 68 in the developing world. Disease onset is typically seven to ten years earlier in men as compared to women.

Browse All Tags